These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 25424750)
21. Inappropriate P-cadherin expression in the mouse mammary epithelium is compatible with normal mammary gland function. Radice GL; Sauer CL; Kostetskii I; Peralta Soler A; Knudsen KA Differentiation; 2003 Aug; 71(6):361-73. PubMed ID: 12919105 [TBL] [Abstract][Full Text] [Related]
22. An Immunohistochemical study of HER-2 expression in feline mammary tumours. Rasotto R; Caliari D; Castagnaro M; Zanetti R; Zappulli V J Comp Pathol; 2011; 144(2-3):170-9. PubMed ID: 20880546 [TBL] [Abstract][Full Text] [Related]
23. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome. Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215 [TBL] [Abstract][Full Text] [Related]
24. Cell proliferation in feline normal, hyperplastic and neoplastic mammary tissue--an immunohistochemical study. Dias Pereira P; Carvalheira J; Gärtner F Vet J; 2004 Sep; 168(2):180-5. PubMed ID: 15301767 [TBL] [Abstract][Full Text] [Related]
25. Grade is an independent prognostic factor for feline mammary carcinomas: a clinicopathological and survival analysis. Seixas F; Palmeira C; Pires MA; Bento MJ; Lopes C Vet J; 2011 Jan; 187(1):65-71. PubMed ID: 19955006 [TBL] [Abstract][Full Text] [Related]
26. Expression of the Short Form of RON/STK in Feline Mammary Carcinoma. Maniscalco L; Guil-Luna S; Iussich S; Gattino F; Trupia C; Millan Y; de Las Mulas JM; Cespedez RS; Saeki K; Accornero P; De Maria R Vet Pathol; 2019 Mar; 56(2):220-229. PubMed ID: 30558510 [TBL] [Abstract][Full Text] [Related]
27. Distribution of Inflammatory Infiltrate in Feline Mammary Lesions: Relationship With Clinicopathological Features. Rodrigues-Jesus J; Canadas-Sousa A; Oliveira P; Figueira AC; Marrinhas C; Petrucci GN; Gregório H; Tinoco F; Goulart A; Felga H; Vilhena H; Dias-Pereira P Vet Comp Oncol; 2024 Sep; 22(3):398-409. PubMed ID: 38863270 [TBL] [Abstract][Full Text] [Related]
28. Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study. Dagher E; Abadie J; Loussouarn D; Fanuel D; Campone M; Nguyen F BMC Vet Res; 2019 Jan; 15(1):25. PubMed ID: 30630524 [TBL] [Abstract][Full Text] [Related]
29. Complex carcinomas of the mammary gland in cats: pathological and immunohistochemical features. Seixas F; Pires MA; Lopes CA Vet J; 2008 May; 176(2):210-5. PubMed ID: 17459738 [TBL] [Abstract][Full Text] [Related]
30. Aberrant subcellular immunolocalization of NOTCH-1 activated intracellular domain in feline mammary tumours. Ressel L; Else RW; Poli A; Argyle DJ J Comp Pathol; 2014 May; 150(4):366-72. PubMed ID: 24529510 [TBL] [Abstract][Full Text] [Related]
31. Correlation of vascular endothelial growth factor expression to overall survival in feline invasive mammary carcinomas. Millanta F; Lazzeri G; Vannozzi I; Viacava P; Poli A Vet Pathol; 2002 Nov; 39(6):690-6. PubMed ID: 12450199 [TBL] [Abstract][Full Text] [Related]
32. Clinicopathological significance of immunoexpression of claudin-1 and claudin-7 in feline mammary carcinomas. Flores AR; Rêma A; Carvalho F; Lopes G; Faustino A; Dias Pereira P J Comp Pathol; 2014 Nov; 151(4):339-46. PubMed ID: 25246182 [TBL] [Abstract][Full Text] [Related]
33. A preliminary investigation of the role of the transcription co-activators YAP/TAZ of the Hippo signalling pathway in canine and feline mammary tumours. Beffagna G; Sacchetto R; Cavicchioli L; Sammarco A; Mainenti M; Ferro S; Trez D; Zulpo M; Michieletto S; Cecchinato A; Goldschmidt M; Zappulli V Vet J; 2016 Jan; 207():105-111. PubMed ID: 26626094 [TBL] [Abstract][Full Text] [Related]
34. P-cadherin expression in feline mammary tissues. Figueira AC; Teodósio AS; Carvalheira J; Lacerda M; de Matos A; Gärtner F Vet Med Int; 2012; 2012():687424. PubMed ID: 23091776 [TBL] [Abstract][Full Text] [Related]
35. Expression of connexins 26 and 43 in canine hyperplastic and neoplastic mammary glands. Torres LN; Matera JM; Vasconcellos CH; Avanzo JL; Hernandez-Blazquez FJ; Dagli ML Vet Pathol; 2005 Sep; 42(5):633-41. PubMed ID: 16145209 [TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical Expression Profiles of Cell Adhesion Molecules, Matrix Metalloproteinases and their Tissue Inhibitors in Central and Peripheral Neoplastic Foci of Feline Mammary Carcinoma. Pisamai S; Rungsipipat A; Kunnasut N; Suriyaphol G J Comp Pathol; 2017; 157(2-3):150-162. PubMed ID: 28942298 [TBL] [Abstract][Full Text] [Related]
37. Activation of AKT in feline mammary carcinoma: a new prognostic factor for feline mammary tumours. Maniscalco L; Iussich S; de Las Mulas JM; Millán Y; Biolatti B; Sasaki N; Nakagawa T; De Maria R Vet J; 2012 Jan; 191(1):65-71. PubMed ID: 21282070 [TBL] [Abstract][Full Text] [Related]
38. Characteristics of the Epithelial-Mesenchymal Transition in Primary and Paired Metastatic Canine Mammary Carcinomas. Raposo-Ferreira TMM; Brisson BK; Durham AC; Laufer-Amorim R; Kristiansen V; Puré E; Volk SW; Sorenmo K Vet Pathol; 2018 Sep; 55(5):622-633. PubMed ID: 29788797 [TBL] [Abstract][Full Text] [Related]
39. Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival. Gama A; Paredes J; Gärtner F; Alves A; Schmitt F Vet J; 2008 Jul; 177(1):45-53. PubMed ID: 17631398 [TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical study of phospho-Stat3-ser727 expression in feline mammary gland tumours. Petterino C; Podestà G; Ratto A; Drigo M; Pellegrino C Vet Res Commun; 2007 Feb; 31(2):173-84. PubMed ID: 17186410 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]